ArticlePharmacoEconomics - open2022

The Cost Effectiveness of Patiromer for the Treatment of Hyperkalaemia in Patients with Chronic Kidney Disease with and without Heart Failure in Ireland.

Thomas Ward et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.